Meeting report: regulatory myeloid cells.

Area of Science:

• Immunology
• Oncology
• Pharmacology

Background:

• Investigating regulatory myeloid cell mobilization in cancer and chronic inflammation.
• Understanding the suppressive mechanisms, pathobiology, and pharmaceutical modulation of myeloid-derived suppressor cells (MDSC).

Framework:

• Addressing controversies on whether MDSC reflect normal physiological responses to stimuli.
• Elucidating molecular features distinguishing MDSC from immature myeloid cells in acute responses.

Implementation:

• Focus on differentiating pathological MDSC roles from normal physiological responses.
• Exploring the contribution of regulatory myeloid cells to inflammatory and malignant diseases.

Implications:

• Potential for MDSC to represent significant deviations from normal acute inflammatory responses.
• Clinical investigations exploring MDSC modulation to enhance cancer immunotherapeutics.